Stay updated on Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe History page now shows a new revision entry (v3.3.2) added and the previous revision (v3.3.1) removed; no changes to the study data, status, or visible content are apparent. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedAdded Revision: v3.3.1 and removed Revision: v3.2.0 in the Record History for NCT05162443.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding notice about potential updates and operating status from the page header. This change does not affect core study information or navigation.SummaryDifference0.8%

- Check42 days agoChange DetectedThe new screenshot shows a slightly reorganized header and updated Record History layout, with the study title, sponsor, and version dates unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange Detected- Added a government funding operating-status notice and updated operating details for NIH Clinical Center (high importance). - Updated version from v3.1.0 to v3.2.0 (moderate importance).SummaryDifference13%

- Check78 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%

Stay in the know with updates to Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.